Biolase, Inc. · OTC:BIOLQ

Biolase — BIOLASE Technology — Investor Presentation (June 2010)

27 slides from Biolase's investor presentation, Jun 9, 2010

  1. Slide 1: Film Short - Waterlase versus the drill on cross section of a tooth

    Film Short - Waterlase versus the drill on cross section of a tooth... 6/9/2010 2 For link on You Tube: http://www.youtube.com/watch?v=QkuwrDajFGY

  2. Slide 2: April 2010 - End-user Shipments Double from Prior Year

    April 2010 - End-user Shipments Double from Prior Year (without iLase shipments) 2009 - Bottom-line restructuring to reach breakeven and survive economic turmoil Determining plans to turn top line Product development for 2010 Q4/Q1 2010 - Top-line restructuring in contracts, sales management and pro

  3. Slide 3: Waterlase Penetration by Metropolitan Statistical Area

    The US has 420 Metropolitan Statistical Areas (MSAs) Waterlase Penetration ranges from 0% to 61% in Each There is Room to Expand NOW 6/9/2010 4 $0.3 Billion $1.6 Billion $4.1 Billion $4.1 Billion $1.9 Billion Penetration by Metropolitan Statistical Area

  4. Slide 4: Strengths: Top Penetration Areas

    Strengths Top 20 Penetration Areas with 6% to 61% Penetration Spread all over the country with varying size Largely a function of effort and location of sales reps Still growing! 6/9/2010 5 Practicing Est MDs Penetration City A, MA 23 14 61% City B, GA 46 11 24% City C, OR 33 4 12% City D, TX 42 5 1

  5. Slide 5: MSAs for Waterlase

    420 MSAs for Waterlase 195,000 Dentists in our US Database 160,000 Dentists are Estimated to be Practicing 6,000 of those Dentists use a Waterlase 67 MSAs with over 5% Waterlase Penetration 19 MSAs with over 7% Penetration 4 MSAs with over 10% Penetration 83 MSAs where there are NO Waterlase AT ALL

  6. Slide 6: MSA Expansion Plan

    MSA Expansion Plan Expanded Sales and Greater Number of Local Events Many MSAs are small and major ones can be broken down Local Waterlase doctors are being contacted and pursued for smaller events being scheduled at their offices Over 34 sessions in 18 cities start this Friday (May 11) Each MSA has

  7. Slide 7: Sales Replacement and Ramp Up

    Sales Replacement and Ramp Up - Nearly All Dental Hires New Proven Sales Leadership Proven from Within 6/9/2010 8 11-13-09 1-1-10 2-1-10 3-1-10 4-1-10 6-1-10 Forecast 8-1-10 Forecast > 2 Years 8 9 9 9 9 11 11 1-2 Years 10 3 3 3 2 4 Months-1 Year 3 3 3 10 14 < 3 Months 2 3 5 11 11 10 11 Total Reps 20

  8. Slide 8: Diode Competitiveness Opening the Door NOW

    Diode Competitiveness Opening the Door NOW Low price diodes came into the market heavily in 2009 Fewer diode and general laser leads iLase launched it February of 2010 Demonstration units being shipped Orders are coming in domestically and from international countries for iLase at very good rate iLa

  9. Slide 9: Up-Sell Strategy: A Total Laser Solution for Every Dentist

    Up-Sell Strategy A Total Laser Solution for Every Dentist 6/9/2010 10 Entry Level All-Tissue common restorative and pediatric procedures The Personal Laser common, everyday soft- tissue procedures Advanced soft- tissue Whitening & Pain Therapy Total Diode Solution common & advanced soft- tissue proc

  10. Slide 10: Historic Biolase Sales Analysis

    Historic 10 Year Biolase Sales Analysis 1998 to 2005 - High growth to slow down 2006 and 2007 - Transition to distribution from direct model Product Lines Under Distribution 2008 and 2009 Sales and Profit Bridge Gave up unprofitable international direct sales, which are expected to rise again under

  11. Slide 11: Historic Analysis 2005 - When growth slowed

    Historic Analysis 2005 - When growth slowed In 2004 growth slowed and in 2005: A new CEO and EVP Sales entered the end of 2004 from the medical industry The Waterlase complexity grew with the introduction of the Waterlase MD The Waterlase price was increased over 30% $10,000 Soft-tissue only diode l

  12. Slide 12: Historic Analysis 2006 - Transitions in Leadership and to Distribution

    Historic Analysis 2006 Additional Transitions in Leadership and to Distribution In 2006: Waterlase prices increased another 13% The new medical CEO was replaced by a previous CEO The new medical EVP Sales was replaced by a previous EVP Sales At year end, the company transitioned from a direct to a d

  13. Slide 13: Historic Analysis - Products Under Distribution Model

    Historic Analysis - Products Under Distribution Model 2006 - 2008 - Diodes and All Other grow double digit, Waterlase declines 2006 Waterlase increases internationally, but decreases domestically 2006 Lasersmile, a $25,000 diode not competitive against $10,000 diode entries 2007 Launch of ezlase dio

  14. Slide 14: 2009 Bridge to Sales Change and Bottom Line Breakeven

    2009 Bridge to Sales Change and Bottom Line Breakeven New CEO Appointed March 2009 after bulk of sales losses in Q1...stock was less than $0.50 2008 vs 2009 Bridge - Critical to achieve approximate non-GAAP breakeven in 2009 A. Demo units and C100 stocking orders for all products in 2008 non-repeati

  15. Slide 15: Historic Analysis Actions Taken on New Deal

    10 Year Historic Analysis Actions Taken on New Deal Price - Waterlase list price dropped to 2006 levels Diodes - Best diode launched with up-sell strategy Medical device issue - Best internally performing DENTAL sales directors and managers promoted, and new hires from dental Distribution - Added fl

  16. Slide 16: Internal and External Independent Studies on Waterlase Adoption

    Internal and External Independent Studies on Waterlase Adoption Internal users (2 years ago): Price - Addressed with iLase and new Waterlase pricing in new deal Speed - Addressed with MD Turbo Training - Addressed over past 2 years External Independent Study (users and non-users last 3 months) Price

  17. Slide 17: Addressing ROI

    Addressing ROI Dr. Rosenberg - Top luminary did a specific ROI presentation now included at http://lasercast.biolase.net/ Dr. Golan - Top luminary did an ROI section in his presentation now included at http://lasercast.biolase.net/ $300 to $600 per day - Simplified return message consistently starte

  18. Slide 18: New Article with Independent ROI Approach

    NEW Article with new independet ROI approach: Surprising trends in laser usage By Roger P. Levin, DDS Dental Economics - March 2010 6/9/2010 19 Introduction Lasers are an excellent instrument for everyday dentistry. This statement may surprise many dentists. But a recent study indicates that highly

  19. Slide 19: Expanding Beyond 5% and 10% Penetration

    Expanding Beyond 5% and 10% Penetration Creating Consumer Demand 6/9/2010 20 $0.3 Billion $1.6 Billion $4.1 Billion $4.1 Billion $1.9 Billion Penetration in various markets

  20. Slide 20: Creating Consumer Demand

    Creating Consumer Demand Strength: Large base of happy dentists and even happier patients Weakness: Non-patients are skeptical of claims "too good to be true" and could believe non-Laser dentists before costly advertising...so another way is needed...a way with evidence they can see and from friends

  21. Slide 21: STEP - Build a base of credible evidence

    STEP 1 - Build a base of credible evidence Been working on development for last 12 months...well underway Establish a base consumer website with references, the whys, testimonials, news references and links to doctors - Done (Over 100,000 hits year now): http://www.laserdentistry.net/ Establish libr

  22. Slide 22: STEP - Get evidence starting to move

    STEP 2 - Get evidence starting to move... Set up Biolase Facebook - Done: Over 1,300 "friends" following NOW already and growing rapidly for regular Biolase updates Hundreds of You Tube examples... Twitter and You Tube sites - Done Personal e-mail blasts (hopefully passed on) to drive friends to see

  23. Slide 23: STEP - Engage the masses

    STEP 3 - Engage the masses Multiple efforts underway and in development now that base of support materials at critical mass... Example: Contest for patients to tell their story to their friends and to tie us in, so we can update them on the latest and greatest going forward Doctors get benefits of f

  24. Slide 24: Reaching out to New Portions of the US Market

    Reaching out to New Portions of the US Market Before the 2006 Henry Schein deal, estimates are that over 85% of sales were non-core Schein accounts Four years after the deal it is estimated that the opposite is true and few sales are non-core Schein Efforts have only just begun to pursue those other

  25. Slide 25: Step - Engage the masses: advertising and P&G deal

    Step 3 - Engage the masses...advertising driving education sites and cross-advertising with doctors...see us on Facebook... Step 4 - Consumer Light Based Products...P&G Deal... Gain comfort with light and lasers in dental care Lasers in all walks of life from internet to grocery check-out Lasers are

  26. Slide 26: Summary

    Summary 2009 - Bottom-line restructuring Q4/Q1 2010 - Top-line restructuring SALES FORCE and SALES LEADERSHIP DISTRIBUTION PRODUCTS TODAY AND MORE TO COME COVERAGE EXPOSURE GROWING APRIL 2010 - First month with all recent changes largely effective Waterlase and ezlase end-user shipments both approxi

  27. Slide 27: Thank You

    Thank You

BIOLASE Technology — Investor Presentation (June 2010) on 6ix